Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials

Michael Gold, Joan Amatniek, Maria C. Carrillo, Jesse M. Cedarbaum, James A. Hendrix, Bradley B. Miller, Julie M. Robillard, J. Jeremy Rice, Holly Soares, Maria B. Tome, Ioannis Tarnanas, Gabriel Vargas, Lisa J. Bain, Sara J. Czaja

Research output: Contribution to journalShort survey

12 Scopus citations

Abstract

Digital technology is transforming the development of drugs for Alzheimer's disease and was the topic of the Alzheimer's Association's Research Roundtable on its May 23–24, 2017 meeting. Research indicates that wearable devices and unobtrusive passive sensors that enable the collection of frequent or continuous, objective, and multidimensional data during daily activities may capture subtle changes in cognition and functional capacity long before the onset of dementia. The potential to exploit these technologies to improve clinical trials as both recruitment and retention tools as well as for potential end points was discussed. The implications for the collection and use of large amounts of data, lessons learned from other related disease areas, ethical concerns raised by these new technologies, and regulatory issues were also covered in the meeting. Finally, the challenges and opportunities of these new technologies for future use were discussed.

Original languageEnglish (US)
Pages (from-to)234-242
Number of pages9
JournalAlzheimer's and Dementia: Translational Research and Clinical Interventions
Volume4
DOIs
StatePublished - Jan 1 2018

Keywords

  • Alzheimer's disease
  • Biomarkers
  • Clinical trials
  • Cognition
  • Digital technology
  • Function

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials'. Together they form a unique fingerprint.

  • Cite this

    Gold, M., Amatniek, J., Carrillo, M. C., Cedarbaum, J. M., Hendrix, J. A., Miller, B. B., Robillard, J. M., Rice, J. J., Soares, H., Tome, M. B., Tarnanas, I., Vargas, G., Bain, L. J., & Czaja, S. J. (2018). Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 4, 234-242. https://doi.org/10.1016/j.trci.2018.04.003